SCHEMBL13635125

SCHEMBL13635125

NCCCn1c2ccccc2c2ccc(C(=O)O)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.61
▸ HPGD P15428 2/20 0.59
▸ ALDH1A1 P00352 1/20 0.59
▸ FABP4 P15090 3/20 0.54
▸ FABP5 Q01469 3/20 0.54
▸ KDM4E B2RXH2 3/20 0.51
▸ CNR2 P34972 2/20 0.50
▸ SYK P43405 2/20 0.49
▸ FABP3 P05413 1/20 0.49
▸ JAK2 O60674 1/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ PSEN1 P49768 5/20 0.46
▸ PSEN2 P49810 5/20 0.46
▸ APH1B Q8WW43 5/20 0.46
▸ NCSTN Q92542 5/20 0.46
▸ APH1A Q96BI3 5/20 0.46
▸ PSENEN Q9NZ42 5/20 0.46
▸ HDAC1 Q13547 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8803334 0.83 ALDH1A1 (0.62) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL13011509 0.83 CNR2 (0.60) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL7407425 0.80 FABP4 (0.56) HPGDFABP4FABP5KDM4ESYK
SCHEMBL27722947 0.80 ALDH1A1 (0.65) PARP1HPGDALDH1A1KDM4E
SCHEMBL13011471 0.80 ALDH1A1 (0.61) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL14292119 0.79 ALDH1A1 (0.56) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL13011475 0.78 PTGER4 (0.58) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL13011140 0.78 ALDH1A1 (0.56) PARP1HPGDALDH1A1FABP4FABP5
SCHEMBL28039674 0.78 CYP19A1 (0.64) PARP1HPGDALDH1A1FABP4KDM4E
SCHEMBL13011521 0.77 ALDH1A1 (0.62) PARP1HPGDALDH1A1FABP4FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2119704-A1 ACYLGUANIDINE DERIVATIVE Astellas Pharma Inc. (JP) 2009-11-18 — — EP disclosed
Send feedback